Completed

Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

HUM Flatter Me

Dietary Supplement
Who is being recruted

Digestive System Diseases+1

+ Gastrointestinal Diseases

+ Gastric Dilatation

From 18 to 45 Years
+13 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Interventional
Study Start: July 2022
See protocol details

Summary

Principal SponsorHUM Nutrition, Inc.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 1, 2022

Actual date on which the first participant was enrolled.

Flatter Me is a product that includes digestive enzymes in a way to support digestion of macronutrients and their constituents and provides herbs traditionally used for digestive health support. This trial aims to test Flatter Me against a placebo pill to examine differences in both subjective outcomes (feelings of bloating and indigestion) and changes in waist circumference (abdominal distension) after eating a test meal.

Official TitleExamining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension
NCT05520411
Principal SponsorHUM Nutrition, Inc.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

25 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 45 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Digestive System DiseasesGastrointestinal DiseasesGastric DilatationStomach Diseases

Criteria

1 inclusion criteria required to participate
Self Report bloating or stomach distension at least once per day after eating
12 exclusion criteria prevent from participating
Females who are pregnant or breastfeeding
Currently taking any prescribed medication meant to treat gut health
Currently taking any medication for fluid balance (i.e., Aldactone)
Currently suffers from any pre-existing condition that would prevent them from adhering to the protocol.
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Come to Citruslabs Office twice (1 Week Gap Between Visits) Visit 1: Take Placebo or Test Product; Eat Test Meal; Outcome Measures Visit 2: Take Placebo or Test Product; Eat Test Meal; Outcome Measures

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Citruslabs

Santa Monica, United StatesOpen Citruslabs in Google Maps
CompletedOne Study Center